...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: BIO Investor Forum, Oct 22-23
6
Sep 16, 2019 04:17PM
4
Oct 18, 2019 10:40AM
3
Oct 18, 2019 02:05PM

Given the radio silence that RVX has imposed on itself, any idea what they will say in San Francisco in the next 2 days? 

 

 

3
Oct 24, 2019 11:14AM
2
Oct 24, 2019 04:18PM
1
Oct 24, 2019 04:42PM
1
Oct 24, 2019 06:04PM
2
Oct 24, 2019 07:51PM
Share
New Message
Please login to post a reply